Hydralazine therapy in severe chronic heart failure: Inability of radionuclide left ventricular ejection fraction measurement to predict the hemodynamic response
From the Department of Medicine, Section of Cardiovascular Diseases, and Department of Radiology, Section of Nuclear Medicine, Sinai Hospital of Detroit and Wayne State University, Detroit, Michigan.